نتایج جستجو برای: mf59

تعداد نتایج: 256  

Journal: :Clinical and vaccine immunology : CVI 2006
Giuseppe Del Giudice Elena Fragapane Roberto Bugarini Maninder Hora Thomas Henriksson Emanuela Palla Derek O'hagan John Donnelly Rino Rappuoli Audino Podda

Squalene is a naturally occurring oil which has been used in the development of vaccine adjuvants, such as the oil-in-water emulsion MF59. In past years, by use of noncontrolled and nonvalidated assays, a claim was made that antisqualene antibodies were detectable in the sera of individuals with the so-called Gulf War syndrome. Using a validated enzyme-linked immunosorbent assay for the quantit...

Journal: :iranian journal of basic medical sciences 0
tamara aghebati nanotechnology research center, mashhad university of medical sciences, mashhad, iran amir hooshang mohammadpour pharmaceutical research center, mashhad university of medical sciences, mashhad, iran mohammad afshar department of anatomy, faculty of medicine, birjand university of medical sciences, birjand, iran medical toxicology research centre, mashhad university of medical sciences, mashhad, iran mahmoud reza jaafari biotechnology research center, mashhad university of medical sciences, mashhad, iran khalil abnous pharmaceutical research center, mashhad university of medical sciences, mashhad, iran

objective(s): in this study, for the first time, mf59 adjuvant was used to develop a cholesteryl ester transfer protein (cetp) vaccine. the efficacy of the vaccine was compared with the efficacy of cetp vaccine formulated with alum/cpg, the formulation that its immunogenicity has been already demonstrated in rabbit and mice. materials and methods: tetanus toxoid- cetp peptide (tt-cetp) was mixe...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2008
F Mosca E Tritto A Muzzi E Monaci F Bagnoli C Iavarone D O'Hagan R Rappuoli E De Gregorio

Oil-in-water emulsions are potent human adjuvants used for effective pandemic influenza vaccines; however, their mechanism of action is still unknown. By combining microarray and immunofluorescence analysis, we monitored the effects of the adjuvants MF59 oil-in-water emulsion, CpG, and alum in the mouse muscle. MF59 induced a time-dependent change in the expression of 891 genes, whereas CpG and...

Journal: :Journal of infection in developing countries 2014
Adib Rodriguez Solares Carlos Grazioso Aragon Rodolfo Urruela Pivaral David Prado-Cohrs Victor Sales-Carmona Michele Pellegrini Nicola Groth

INTRODUCTION The efficacy of non-adjuvanted seasonal influenza vaccine in young children is considered to be suboptimal. This study compared the safety and immunogenicity profiles of MF59-adjuvanted, trivalent, influenza vaccine (ATIV) and non-adjuvanted, trivalent, influenza vaccine (TIV) in Guatemalan children (N = 360) between 6 and < 60 months of age. METHODOLOGY Children received two dos...

Azam Bolhassani, Fateme Asgar Halvaee, Mehdi Mahdavi, Mohammad Mehdi Aslani, Mohammad Reza Aghasadeghi, Seyed Davar Siadat, Seyed Mehdi Sadat, Seyed Mohammad Mahdi Ghahari, Soheila Hekmat,

Background: A licensed vaccine against hepatitis C virus (HCV) has not become available to date. The stability and antigenicity of a targeted synthesized recombinant fusion protein consisting of a truncated core and NS3 (rC/N) of HCV had been predicted. Although safe antigens, recombinant proteins are not efficacious vaccines without adjuvants. The present study evaluated the immunogenicity of ...

Introduction: Hepatitis is a systemic diseasethat causes liver inflammation. The prevention of this infection is a vaccination. The commonly used vaccine to fight this disease is to use the vaccine formulated with Alum. This vaccine cannot provide immune response and complete productivity in some people. In this study, cellular and humoral immune responses of hepatitis B vaccine were compared w...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2009
Grazia Galli Kathy Hancock Katja Hoschler Joshua DeVos Michaela Praus Monia Bardelli Carmine Malzone Flora Castellino Chiara Gentile Teresa McNally Giuseppe Del Giudice Angelika Banzhoff Volker Brauer Emanuele Montomoli Maria Zambon Jacqueline Katz Karl Nicholson Iain Stephenson

Proactive priming before the next pandemic could induce immune memory responses to novel influenza antigens. In an open-label study, we analyzed B cell memory and antibody responses of 54 adults who received 2 7.5-microg doses of MF59-adjuvanted A/Vietnam/1194/2004 clade 1 (H5N1) vaccine. Twenty-four subjects had been previously primed with MF59-adjuvanted or plain clade 0-like A/duck/Singapore...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2013
Maria Vono Marianna Taccone Paola Caccin Marilena Gallotta Giovanna Donvito Simonetta Falzoni Emiliano Palmieri Michele Pallaoro Rino Rappuoli Francesco Di Virgilio Ennio De Gregorio Cesare Montecucco Anja Seubert

Vaccines are the most effective agents to control infections. In addition to the pathogen antigens, vaccines contain adjuvants that are used to enhance protective immune responses. However, the molecular mechanism of action of most adjuvants is ill-known, and a better understanding of adjuvanticity is needed to develop improved adjuvants based on molecular targets that further enhance vaccine e...

Journal: :Journal of immunology 2008
Anja Seubert Elisabetta Monaci Mariagrazia Pizza Derek T O'Hagan Andreas Wack

Aluminum hydroxide (alum) and the oil-in-water emulsion MF59 are widely used, safe and effective adjuvants, yet their mechanism of action is poorly understood. We assessed the effects of alum and MF59 on human immune cells and found that both induce secretion of chemokines, such as CCL2 (MCP-1), CCL3 (MIP-1alpha), CCL4 (MIP-1beta), and CXCL8 (IL-8), all involved in cell recruitment from blood i...

2014
Surender Khurana Elizabeth M. Coyle Milena Dimitrova Flora Castellino Karl Nicholson Giuseppe Del Giudice Hana Golding

In an open label clinical study (2007), MF59-adjuvanted hemagglutinin (HA) vaccine from H5N1-A/Vietnam/1194/2004 (clade 1) was administered to subjects previously vaccinated (primed) with clade 0 H5N3 (A/duck/Singapore/97) vaccine at least 6 years earlier (in 1999 or 2001). The primed individuals responded rapidly and generated high neutralizing antibody titers against the H5N1-Vietnam strain w...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید